KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) FCF Payout Ratio (2016 - 2026)

Pfizer has reported FCF Payout Ratio over the past 18 years, most recently at 1.12 for Q1 2026.

  • Quarterly FCF Payout Ratio fell 18.46% to 1.12 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 1.03 through Mar 2026, down 75.63% year-over-year, with the annual reading at 1.08 for FY2025, 11.33% up from the prior year.
  • FCF Payout Ratio was 1.12 for Q1 2026 at Pfizer, up from 0.54 in the prior quarter.
  • Over five years, FCF Payout Ratio peaked at 31.55 in Q2 2023 and troughed at 2.04 in Q2 2025.
  • The 5-year median for FCF Payout Ratio is 0.55 (2023), against an average of 2.77.
  • The largest YoY upside for FCF Payout Ratio was 8173.45% in 2023 against a maximum downside of 460.69% in 2023.
  • A 5-year view of FCF Payout Ratio shows it stood at 0.37 in 2022, then soared by 51.07% to 0.55 in 2023, then skyrocketed by 220.69% to 1.77 in 2024, then plummeted by 69.31% to 0.54 in 2025, then surged by 106.65% to 1.12 in 2026.
  • Per Business Quant, the three most recent readings for PFE's FCF Payout Ratio are 1.12 (Q1 2026), 0.54 (Q4 2025), and 0.61 (Q3 2025).